© 2002 by Oxford University Press
Journal of the National Cancer Institute, Vol. 94, No. 14, 1044-1045,
July 17, 2002
© 2002 Oxford University Press
EDITORIAL |
Attribution of Deaths Following Cancer Treatment
Affiliation of authors: Health Outcomes Group, Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY.
Correspondence to: Colin B. Begg, Ph.D., Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, 1275 York Ave., New York, NY 10021 (e-mail: beggc@mskcc.org).
| The first 150 words of the full text of this article appear below. |
Government agencies provide regular reports on progress in the fight against cancer, and these reports are viewed with great interest by researchers and by the media (1). The primary measures of the cancer burden are cancer incidence rates and cancer mortality rates. The latter are derived from state death certificates, which are completed by physicians, medical examiners, coroners, and funeral directors, and collated by the National Center for Health Statistics (NCHS) (2). The data from death certificates are compiled using the World Health Organization schema to determine the underlying cause of death. The classification rules are changed periodically; most recently in 1999 with the adoption of the Tenth Revision of the International Statistical Classification of Diseases and Related Health Problems (ICD) (3). This general approach leads to the designation of a unitary "underlying" cause for each death. In practice, a death
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
B. B. Barone, H.-C. Yeh, C. F. Snyder, K. S. Peairs, K. B. Stein, R. L. Derr, A. C. Wolff, and F. L. Brancati Long-term All-Cause Mortality in Cancer Patients With Preexisting Diabetes Mellitus: A Systematic Review and Meta-analysis JAMA, December 17, 2008; 300(23): 2754 - 2764. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Nattinger, P. W. Laud, R. A. Sparapani, X. Zhang, J. M. Neuner, and M. A. Gilligan Exploring the Surgeon Volume Outcome Relationship Among Women With Breast Cancer Arch Intern Med, October 8, 2007; 167(18): 1958 - 1963. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Lambert, J. R. Thompson, C. L. Weston, and P. W. Dickman Estimating and modeling the cure fraction in population-based cancer survival analysis Biostat., July 1, 2007; 8(3): 576 - 594. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. N. Neuss, C. E. Desch, K. K. McNiff, P. D. Eisenberg, D. H. Gesme, J. O. Jacobson, M. Jahanzeb, J. J. Padberg, J. M. Rainey, J. J. Guo, et al. A Process for Measuring the Quality of Cancer Care: The Quality Oncology Practice Initiative J. Clin. Oncol., September 1, 2005; 23(25): 6233 - 6239. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Berlin Potential Legal Ramifications of Whole-Body CT Screening: Taking a Peek into Pandora's Box Am. J. Roentgenol., February 1, 2003; 180(2): 317 - 322. [Full Text] [PDF] |
||||




